Atracurium
Back to searchMolecule Structure
Scientific Name
Atracurium
Brand Name(s)
Not Available
Company Owner(s)
Mylan Laboratories Ltd, Hospira Inc, Baxter Healthcare Corp Anesthesia And Critical Care, Watson Laboratories Inc, Teva Parenteral Medicines Inc, Eugia Pharma Specialities Ltd, Meitheal Pharmaceuticals Inc, Baxter Healthcare Corp Anesthesia Critical Care, Hikma Pharmaceuticals Usa Inc, Watson Pharmaceuticals Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Muscle-type nicotinic acetylcholine receptor | PROTEIN COMPLEX GROUP | ANTAGONIST | CHEMBL2362997 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL7773510 | |
| PharmGKB | PA164776840 | |
| Human Metabolome Database | HMDB0014870 | |
| PubChem: Thomson Pharma | 14938770 | |
| PubChem | 47319 | |
| LINCS | LSM-5147 | |
| Nikkaji | J292.641E | |
| BindingDB | 92478 | |
| EPA CompTox Dashboard | DTXSID9043726 | |
| DrugCentral | 259 | |
| ChemicalBook | CB62130242 | CB9379882 |
| Guide to Pharmacology | 9537 | |
| rxnorm | ATRACURIUM BESYLATE | ATRACURIUM |
| KEGG Ligand | C07548 | |
| ChEBI | 2914 |
